Xenografts and cell lines derived from patients with CIC::DUX4-driven sarcomas have hyperactivation of the PI3K/AKT pathway through autocrine signaling by high-mobility group A (HMGA) and insulin-like growth factor (IGF) proteins (Carrabotta et al., 2022). The gene discussed is DUX4; the disease is sarcoma.